D Cardinale

Summary

Affiliation: European Institute of Oncology
Country: Italy

Publications

  1. doi request reprint Anthracycline-induced cardiomyopathy: clinical relevance and response to pharmacologic therapy
    Daniela Cardinale
    Cardiology Unit, European Institute of Oncology, Istituto di Ricovero e Cura a Carattere Scientifico, Milan, Italy
    J Am Coll Cardiol 55:213-20. 2010
  2. pmc Cardio-oncology: a new medical issue
    D Cardinale
    Cardiology Unit and Laboratory Medicine Unit, European Institute of Oncology, IRCCS, 20141 Milan, Italy
    Ecancermedicalscience 2:126. 2008
  3. doi request reprint Strategies to prevent and treat cardiovascular risk in cancer patients
    Daniela Cardinale
    Cardioncology Unit, European Institute of Oncology, Milan, Italy
    Semin Oncol 40:186-98. 2013
  4. doi request reprint [Cardioprotection in women with neoplastic disease]
    Daniela Cardinale
    Istituto Europeo di Oncologia, IRCCS, Milano
    G Ital Cardiol (Rome) 13:461-8. 2012
  5. ncbi request reprint Prevention of high-dose chemotherapy-induced cardiotoxicity in high-risk patients by angiotensin-converting enzyme inhibition
    Daniela Cardinale
    Cardiology Unit, European Institute of Oncology, Via Ripamonti 435, 20141 Milan, Italy
    Circulation 114:2474-81. 2006
  6. pmc Acute coronary syndrome induced by oral capecitabine
    Daniela Cardinale
    Cardiology Unit, European Institute of Oncology, Milan, Italy
    Can J Cardiol 22:251-3. 2006
  7. doi request reprint Trastuzumab-induced cardiotoxicity: clinical and prognostic implications of troponin I evaluation
    Daniela Cardinale
    Cardiology Unit, European Institute of Oncology, Milan, Italy
    J Clin Oncol 28:3910-6. 2010
  8. doi request reprint Role of biomarkers in chemotherapy-induced cardiotoxicity
    Daniela Cardinale
    Cardiology Unit, European Institute of Oncology, I R C C S, Milan, Italy
    Prog Cardiovasc Dis 53:121-9. 2010
  9. doi request reprint Assessment of cardiotoxicity with cardiac biomarkers in cancer patients
    D Cardinale
    Cardiology Unit, European Institute of Oncology, Milan, Italy
    Herz 36:325-32. 2011
  10. ncbi request reprint Prognostic value of troponin I in cardiac risk stratification of cancer patients undergoing high-dose chemotherapy
    Daniela Cardinale
    Cardiology Unit, Istituto Europeo di Oncologia, University of Milan, Via Ripamonti 435, 20141 Milan, Italy
    Circulation 109:2749-54. 2004

Collaborators

Detail Information

Publications28

  1. doi request reprint Anthracycline-induced cardiomyopathy: clinical relevance and response to pharmacologic therapy
    Daniela Cardinale
    Cardiology Unit, European Institute of Oncology, Istituto di Ricovero e Cura a Carattere Scientifico, Milan, Italy
    J Am Coll Cardiol 55:213-20. 2010
    ..The purpose of this study was to evaluate the clinical relevance of anthracycline-induced cardiomyopathy (AC-CMP) and its response to heart failure (HF) therapy...
  2. pmc Cardio-oncology: a new medical issue
    D Cardinale
    Cardiology Unit and Laboratory Medicine Unit, European Institute of Oncology, IRCCS, 20141 Milan, Italy
    Ecancermedicalscience 2:126. 2008
    ..Cardio-oncology deals with the following main clinical and research areas: early diagnosis of cardiotoxicity, risk stratification and preventions, treatment and monitoring of cardiotoxicity...
  3. doi request reprint Strategies to prevent and treat cardiovascular risk in cancer patients
    Daniela Cardinale
    Cardioncology Unit, European Institute of Oncology, Milan, Italy
    Semin Oncol 40:186-98. 2013
    ..Specific guidelines that take cardiologic conditions of cancer patients into account are currently lacking and need to be developed...
  4. doi request reprint [Cardioprotection in women with neoplastic disease]
    Daniela Cardinale
    Istituto Europeo di Oncologia, IRCCS, Milano
    G Ital Cardiol (Rome) 13:461-8. 2012
    ....
  5. ncbi request reprint Prevention of high-dose chemotherapy-induced cardiotoxicity in high-risk patients by angiotensin-converting enzyme inhibition
    Daniela Cardinale
    Cardiology Unit, European Institute of Oncology, Via Ripamonti 435, 20141 Milan, Italy
    Circulation 114:2474-81. 2006
    ..Angiotensin-converting enzyme inhibitors slow the progression of left ventricular dysfunction in different clinical settings, but their role in the prevention of cardiotoxicity has never been investigated...
  6. pmc Acute coronary syndrome induced by oral capecitabine
    Daniela Cardinale
    Cardiology Unit, European Institute of Oncology, Milan, Italy
    Can J Cardiol 22:251-3. 2006
    ..After a nine-month follow-up, she remains alive, with a good performance status and without clinical evidence of persistent ischemia...
  7. doi request reprint Trastuzumab-induced cardiotoxicity: clinical and prognostic implications of troponin I evaluation
    Daniela Cardinale
    Cardiology Unit, European Institute of Oncology, Milan, Italy
    J Clin Oncol 28:3910-6. 2010
    ..The usefulness of troponin I (TNI) in the identification of patients at risk for TIC and in the prediction of LVEF recovery has never been investigated...
  8. doi request reprint Role of biomarkers in chemotherapy-induced cardiotoxicity
    Daniela Cardinale
    Cardiology Unit, European Institute of Oncology, I R C C S, Milan, Italy
    Prog Cardiovasc Dis 53:121-9. 2010
    ..Therefore, we propose troponin as a criterion standard marker for the assessment of cardiac risk of both old and new antineoplastic treatments, and its evaluation should be included among the criteria utilized to define cardiotoxicity...
  9. doi request reprint Assessment of cardiotoxicity with cardiac biomarkers in cancer patients
    D Cardinale
    Cardiology Unit, European Institute of Oncology, Milan, Italy
    Herz 36:325-32. 2011
    ..The use of a multimarker approach may provide a unique opportunity for advancement in this field, allowing for better stratification of the cardiac risk in cancer patients treated with anticancer drugs...
  10. ncbi request reprint Prognostic value of troponin I in cardiac risk stratification of cancer patients undergoing high-dose chemotherapy
    Daniela Cardinale
    Cardiology Unit, Istituto Europeo di Oncologia, University of Milan, Via Ripamonti 435, 20141 Milan, Italy
    Circulation 109:2749-54. 2004
    ..The time course of the subclinical myocardial damage and its impact on the clinical outcome have never been investigated previously...
  11. ncbi request reprint Myocardial injury revealed by plasma troponin I in breast cancer treated with high-dose chemotherapy
    D Cardinale
    Cardiology Unit, Istituto Europeo di Oncologia, University of Milan, Italy
    Ann Oncol 13:710-5. 2002
    ..We investigated the role of plasma troponin I (TnI) in this setting...
  12. ncbi request reprint Left ventricular dysfunction predicted by early troponin I release after high-dose chemotherapy
    D Cardinale
    Cardiology Unit, Istituto Europeo di Oncologia, University of Milan, Italy
    J Am Coll Cardiol 36:517-22. 2000
    ..We investigated the role of cardiac troponin I (cTnI) in patients with aggressive malignancies treated with high-dose chemotherapy (HDC)...
  13. ncbi request reprint Increased perioperative N-terminal pro-B-type natriuretic peptide levels predict atrial fibrillation after thoracic surgery for lung cancer
    Daniela Cardinale
    Cardiology Unit, European Institute of Oncology, IRCCS, Via Ripamonti 435, 20141 Milan, Italy
    Circulation 115:1339-44. 2007
    ..We performed a prospective study to evaluate the role of N-terminal pro-B-type natriuretic peptide (NT-proBNP) as a marker for risk stratification of postoperative AF in patients undergoing thoracic surgery for lung cancer...
  14. ncbi request reprint Atrial fibrillation after operation for lung cancer: clinical and prognostic significance
    D Cardinale
    Cardiology Unit and Thoracic Surgery Division, Istituto Europeo di Oncologia, University of Milan, Italy
    Ann Thorac Surg 68:1827-31. 1999
    ..Its clinical incidence and short- and long-term impact on overall mortality has never been definitely assessed; moreover, it is unclear whether the arrhythmia represents an independent cardiac risk factor...
  15. ncbi request reprint Cardiovascular toxicity induced by chemotherapy, targeted agents and radiotherapy: ESMO Clinical Practice Guidelines
    G Curigliano
    Department of Medicine, Division of Medical Oncology, European Institute of Oncology, Milan, Italy
    Ann Oncol 23:vii155-66. 2012
    ....
  16. pmc Long QT syndrome and torsade de pointes after anthracycline chemotherapy
    N Colombo
    Cardiology Unit, European Institute of Oncology, I R C C S, Milan, Italy
    Ecancermedicalscience 3:147. 2009
    ....
  17. ncbi request reprint Intrapericardial treatment of neoplastic pericardial effusions
    A Martinoni
    Cardiology Unit, European Institute of Oncology IRCCS, University of Milan, Milan, Italy
    Herz 25:787-93. 2000
    ..Real randomized, case-control studies are moreover required to assess the gold standard of malignant pericardial effusions treatment...
  18. pmc QTc prolongation assessment in anticancer drug development: clinical and methodological issues
    G Curigliano
    Division of Medical Oncology, European Institute of Oncology, I R C C S, Milan, Italy
    Ecancermedicalscience 3:130. 2009
    ..A thoughtful risk management plan generated by an organized collaboration between oncologists, cardiologists, and regulatory agencies to support a development programme essential for oncology agents with cardiac safety concerns...
  19. ncbi request reprint Minor increases in plasma troponin I predict decreased left ventricular ejection fraction after high-dose chemotherapy
    Maria Teresa Sandri
    Division of Pathology, Laboratory Medicine Unit, European Institute of Oncology, Via Ripamonti 435, 20141 Milan, Italy
    Clin Chem 49:248-52. 2003
    ..We investigated whether cTnI measured by the Stratus CS (Dade Behring) would allow detection of minimal cTnI increases in patients treated with HDCT...
  20. ncbi request reprint N-terminal pro-B-type natriuretic peptide after high-dose chemotherapy: a marker predictive of cardiac dysfunction?
    Maria T Sandri
    Epidemiology and Biostatistics Division, Hematoncology Division, European Institute of Oncology, Milan, Italy
    Clin Chem 51:1405-10. 2005
    ..Recently, N-terminal pro-B-type natriuretic peptide (NT-proBNP) was implicated as a marker of CHF. In this study we evaluated the predictive role of NT-proBNP in patients treated with high-dose chemotherapy (HDC)...
  21. ncbi request reprint Early reduction in left ventricular contractile reserve detected by dobutamine stress echo predicts high-dose chemotherapy-induced cardiac toxicity
    Maurizio Civelli
    Cardiology Unit, European Institute of Oncology, University of Milan, Italy
    Int J Cardiol 111:120-6. 2006
    ....
  22. doi request reprint Atrial fibrillation after thoracic surgery for lung cancer: use of a single cut-off value of N-terminal pro-B type natriuretic peptide to identify patients at risk
    Michela Salvatici
    European Institute of Oncology, Milan, Italy
    Biomarkers 15:259-65. 2010
    ..3 ng l(-1) can be used to select high-risk patients who could receive preventive therapy, leading to a considerable decrease in the total costs associated with the management of this complication...
  23. doi request reprint Biochemical markers for prediction of chemotherapy-induced cardiotoxicity: systematic review of the literature and recommendations for use
    Alberto Dolci
    Clinical Chemistry Laboratory, Hospital Luigi Sacco, University of Milan, Milan, Italy
    Am J Clin Pathol 130:688-95. 2008
    ..Concerning cardiac natriuretic peptides, definitive evidence in regard to a diagnostic or prognostic role in predicting chemotherapy-induced cardiomyopathy is still lacking...
  24. ncbi request reprint Optimizing clinical care of patients with metastatic breast cancer: a new oral vinorelbine plus trastuzumab combination
    C Catania
    Division of Medical Oncology, Unit for Medical Care, Department of Medicine, European Institute of Oncology, Milan, Italy
    Ann Oncol 18:1969-75. 2007
    ..In order to further improve quality of life of patients undergoing treatment for ABC, a new regimen using oral vinorelbine (oVNR) (d1 + d3) plus q3wks T was tested (ToVNR)...
  25. ncbi request reprint Long-term results of intrapericardial chemotherapeutic treatment of malignant pericardial effusions with thiotepa
    Alessandro Martinoni
    Cardiology Unit, Via Ripamonti 435, Milan, Italy
    Chest 126:1412-6. 2004
    ..This study was performed in order to investigate the long-term effects of intracavitary treatment with thiotepa in the reduction of pericardial effusion (PE) recurrences...
  26. doi request reprint Circulating cytochrome c as potential biomarker of impaired reperfusion in ST-segment elevation acute myocardial infarction
    Giancarlo Marenzi
    Centro Cardiologico Monzino, IRCCS, Department of Cardiovascular Sciences, University of Milan, Milan, Italy
    Am J Cardiol 106:1443-9. 2010
    ..20 to 2.20, vs 1.1 ng/ml, interquartile range 0.65 to 1.55; p = 0.04). In conclusion, serum cytochrome c is detectable in the early phase of STEMI treated with pPCI and is associated with clinical signs of impaired myocardial reperfusion...
  27. ncbi request reprint Troponin I and cardiovascular risk stratification in patients with testicular cancer
    Daniela Cardinale
    J Clin Oncol 24:3508; author reply 3508-9. 2006
  28. ncbi request reprint [Biochemical markers for predicting chemotherapy-induced cardiotoxicity: systematic review of the literature and recommendations for use]
    Alberto Dolci
    Laboratorio Analisi Chimico Cliniche, A O Luigi Sacco
    G Ital Cardiol (Rome) 7:604-11. 2006
    ....